Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 27.3647.7027.698.479.60

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 27.36 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,571.6 Cr -2.1% 6.5% 61.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,728.0 Cr -0.8% 7.4% 8.6% Stock Analytics
DIVIS LABORATORIES ₹167,236.0 Cr -1.5% 5.7% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,951.0 Cr -1.8% 8.8% 44.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,765.0 Cr -1.2% 9.2% 14.9% Stock Analytics
CIPLA ₹106,033.0 Cr -2.5% 0.1% -7.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.1%

6.5%

61.3%

SENSEX

-3.8%

-2%

6.3%


You may also like the below Video Courses